Clinical Trials Browser

Phase 2 × Tretinoin × Lymphoid × Clear all

NCT06646666 2024-11-01

ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT

Phase 2 Not yet recruiting

Lymphoma, B-Cell

NCT00002479 2012-05-30

Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome

Phase 2 Completed

DermatologicLymphoid

Lymphoma, Lymphoma, T-Cell, Cutaneous